Zidovudine use to reduce perinatal HIV type 1 transmission in an urban medical center

JAMA

Volumn 275, Issue 19, 1996, Pages 1504-1506

  Wiznia, Andrew A ^a,b,c   Crane, Marilyn ^a,b   Lambert, Genevieve ^a,b   Sansary, Jorge ^a   Harris, Adell ^a   Solomon, Laurie ^a,b  

^a Lebanon Hospital Center   (United States)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^c BRONX LEBANON HOSPITAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ZIDOVUDINE;

ADULT; ARTICLE; COMMUNITY HOSPITAL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION PREVENTION; INFECTION RISK; INTRAVENOUS DRUG ABUSE; MAJOR CLINICAL STUDY; MALE; ORAL DRUG ADMINISTRATION; PATIENT COMPLIANCE; PERINATAL INFECTION; PRIORITY JOURNAL; URBAN AREA; VERTICAL TRANSMISSION; VIRUS TRANSMISSION;

EID: 0029966015     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.275.19.1504     Document Type: Article

References (17)

1. Oxtoby MJ. Vertically acquired HIV infection in the United States. In: Pizzo PA, Wilfert CM, eds. Pediatric AIDS: The Challenge of HIV Infection in Infants, Children and Adolescents. 2nd Ed. Baltimore, Md: Williams & Wilkins; 1994:3-20.
2. Connor EM, Sperling R, Gelfer R, et al. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. N Engl J Med. 1994;31:1173-1180.
3. Centers for Disease Control and Prevention. US Public Health Service recommendations for human immunodeficiency virus counseling and voluntary testing for pregnant women. MMWR Morb Mortal Wkly Rep. 1995;44:1-14.
4. Centers for Disease Control and Prevention. Recommendations of the US Public Health Services Task Force on the use of zidovudine to reduce perinatal transmission of human immunodeficiency virus. MMWR Morb Mortal Wkly Rep. 1994;43(RR-11):1-20.
5. State of New York Dept of Health, AIDS Institute. Clinical Guidelines for the Use of Zidovudine Therapy in Pregnancy to Reduce Perinatal Transmission of HIV. Albany: State of New York Dept of Health; 1994.
6. Bayer R. Ethical challenges posed by zidovudine treatment to reduce vertical transmission of HIV. N Engl J Med. 1994;331:1223-1226.
7. Rogers M, Jaffe H. Reducing the risk of maternal-infant transmission of HIV: a door is opened. N Engl J Med. 1994;331:1223-1225.
8. Centers for Disease Control and Prevention. Epi Info, Version 6: A Word Processing, Database, and Statistics System for Epidemiology on Microcomputers. Atlanta, Ga: Centers for Disease Control and Prevention; 1994.
9. Davis SF, Byers RH, Lindegren ML, Caldwell B, Karon JM, Gwinn M. Prevalence and incidence of vertically acquired HIV infection in the United States. JAMA 1995;274:952-955.
10. Giovino GA, Henningfield JE, Tomar SL, Escobedo LG, Slade J. Epidemiology of tobacco use and dependence. Epidemiol Rev. 1995;17:48-65.
11. Wehbeh H, Matthews RP, McCall S, Heldman J, Minkoff HL. The effects of recent cocaine use on the progress of labor. Am J Obstet Gynecol. 1995;172: 1014-1018.
12. Plessinger MA, Woods JR Jr. Maternal, placental, and fetal pathophysiology of cocaine exposure during pregnancy. Clin Obstet Gynecol. 1993;36:267-278.
13. Burkett G, Yassin SY, Palow D, LaVoie L, Martinez M. Patterns of cocaine binging: effect on pregnancy. Am J Obstet Gynecol. 1994;171:372-378.
14. Rodriguez EM, Mofenson LM, Chang B-H, et al, for the Women and Infants Transmission Study. Association of maternal drug use during pregnancy with maternal HIV culture positivity and perinatal HIV transmission. AIDS. 1996;10:273-282.
15. Executive Summary, ACTG 152: A Randomized Comparative Trial of Zidovudine (ZDV) vs 2′3′-dideoxyinosine (ddI) vs ZDV Plus ddI in Symptomatic HIV-Infected Children. Washington, DC: US Dept of Health and Human Services; 1995.
16. Executive Summary, ACTG 175: A Randomized, Double Blind Phase II/III Trial of Monotherapy With vs Combination Therapy With Nucleoside Analogues in HIV-Infected Persons With CD4 Cells >200 and <500 Cells/cmm. Washington, DC: US Dept of Health and Human Services; September 1995.
17. Lester P, Partridge JC, Chesney MA, Cooke M. The consequences of a positive prenatal HIV antibody test for women. J Acquir Immune Defic Syndr Hum Retrovirol. 1995;10:341-349.